World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
80
Citations
26631
World Ranking
1146
National Ranking
519

Medicine

D-Index
80
Citations
26696
World Ranking
17006
National Ranking
8528

Overview

David Katzenstein was affiliated with Stanford University in the United States. Their research primarily contributed to the fields of Medicine and Immunology and Microbiology, with a specialized focus on Infectious Diseases and Virology as key subfields.

Their work centered on several main topics, including:

  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • HIV-related health complications and treatments
  • HIV, Drug Use, Sexual Risk
  • Cervical Cancer and HPV Research
  • Reproductive tract infections research

David Katzenstein published extensively in several venues, often contributing to:

  • UNC Libraries
  • AIDS Research and Human Retroviruses
  • International Journal of Infectious Diseases
  • Journal of Clinical Microbiology
  • PLoS ONE

Their frequent collaborators included:

  • Vinie Kouamou
  • Justen Manasa
  • Kathy McCarty
  • Tinei Shamu
  • Tichaona Mapangisana

Among their recent publications were:

  • Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe, 2020, BMC Women's Health
  • Drug Resistance Among Adolescents and Young Adults with Virologic Failure of First-Line Antiretroviral Therapy and Response to Second-Line Treatment, 2020, AIDS Research and Human Retroviruses
  • Public availability of HIV-1 drug resistance sequence and treatment data: a systematic review, 2022, The Lancet Microbe
  • Mother-to-child transmission of HIV-1 and infant mortality in the first six months of life, in the era of Option B Plus combination antiretroviral therapy, 2021, International Journal of Infectious Diseases
  • Whole-Genome Analysis of Cervical Human Papillomavirus Type 35 from rural Zimbabwean Women, 2020, Scientific Reports

Best Publications

  • A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

    Scott M. Hammer;David A. Katzenstein;Michael D. Hughes;Holly Gundacker

  • Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society–USA Panel

    Charles C. J. Carpenter;David A. Cooper;Margaret A. Fischl;Jose M. Gatell

  • Treatment for adult HIV infection : 2006 recommendations of the international AIDS society-USA panel

    Scott M. Hammer;Michael S. Saag;Mauro Schechter;Julio S. G. Montaner

  • Antiretroviral Therapy for HIV Infection in 1997: Updated Recommendations of the International AIDS Society—USA Panel

    Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch

  • Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel

    Patrick G. Yeni;Scott M. Hammer;Charles C. J. Carpenter;David A. Cooper

  • Antiretroviral Therapy for HIV Infection in 1998: Updated Recommendations of the International AIDS Society–USA Panel

    Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch

  • Antiretroviral therapy for HIV infection in 1996 : Recommendations of an international panel

    Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch

  • Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

    Patrick G. Yeni;Scott M. Hammer;Martin S. Hirsch;Michael S. Saag

  • The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter

    David A. Katzenstein;Scott M. Hammer;Michael D. Hughes;Holly Gundacker

  • The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan

    Victor DeGruttola;Lynn Dix;Richard D'Aquila;Dan Holder

  • Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.

    Paul E. Sax;Camlin Tierney;Ann C. Collier;Margaret A. Fischl

  • Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1

    Eric S. Daar;Camlin Tierney;Margaret A. Fischl;Paul E. Sax

  • Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration

    Rami Kantor;David A Katzenstein;Brad Efron;Ana Patricia Carvalho

  • Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.

    Scott M Hammer;Michael S Saag;Mauro Schechter;Julio S G Montaner

  • A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection

    J. C. McArthur;C. Yiannoutsos;D. M. Simpson;B. T. Adornato

  • Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral Therapy

    Ian C. Marschner;Ann C. Collier;Robert W. Coombs;Richard T. D'Aquila

  • Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy.

    M. Polydefkis;C. T. Yiannoutsos;Bruce Arnold Cohen;H. Hollander

  • Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis

    Soo Yon Rhee;Jose Luis Blanco;Michael R. Jordan;Jonathan Taylor

  • Inhibition of human immunodeficiency virus gene amplification by heparin.

    M. Holodniy;Sue Kim;D. Katzenstein;M. Konrad

  • HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed.

    Andrew R. Zolopa;Robert W. Shafer;Ann Warford;Jose G. Montoya

Frequent Co-Authors

Robert W. Shafer
Robert W. Shafer Stanford University
Thomas C. Merigan
Thomas C. Merigan Stanford University
Scott M. Hammer
Scott M. Hammer Columbia University
Mark A. Winters
Mark A. Winters Stanford University
Lynn Morris
Lynn Morris University of the Witwatersrand
Margaret A. Fischl
Margaret A. Fischl University of Miami
Mark Holodniy
Mark Holodniy Stanford University
Jonathan M. Schapiro
Jonathan M. Schapiro Sheba Medical Center
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Anne-Mieke Vandamme
Anne-Mieke Vandamme Rega Institute for Medical Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology opens doors to various exciting career paths, many of which are accessible through online degrees. For those concerned about barriers to education, options like degrees for felons offer programs designed to help individuals rebuild their careers in healthcare and science fields.

One growing area within healthcare is functional medicine, where professionals focus on personalized patient care. Aspiring practitioners can explore functional medicine NP programs to become nurse practitioners specializing in this innovative approach.

Beyond clinical roles, microbiology graduates may pursue careers in health information and coding. For instance, becoming a certified professional coder can be lucrative; detailed information about cpc medical coding salary and career growth helps in making informed decisions.

Another vital role in the healthcare system is health information management. A specialized degree in this area provides strong job prospects and stable income, with insights available on health information management degree salary.

Overall, combining a microbiology background with any of these related degrees can enhance career flexibility and open diverse professional opportunities.

Best Scientists Citing David Katzenstein

Recently Published Articles